Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
856. Elliott AM, Nakiyingi J, Quigley MA, French N, Gilks CF, Whitworth JAG.<br />
Inverse association between BCG immunisation <strong>and</strong> intestinal nematode infestation<br />
among HIV-1-positive individuals in Ug<strong>and</strong>a. Lancet 1999; 354: 1000-1.<br />
857. Odent M. Future of BCG. (Correspondence). Lancet 1999; 354: 2170.<br />
858. Styblo K, Meijer J. Impact of BCG vaccination programmes in children <strong>and</strong><br />
young adults on the tuberculosis problem. Tubercle 1976; 57: 17-43.<br />
859. Rouillon A, Waaler H. BCG vaccination <strong>and</strong> epidemiological situation. Adv<br />
Tuberc Res 1976; 19: 64-126.<br />
860. World Health Organization. BCG vaccination policies. Report of a WHO Study<br />
Group. Tech Rep Ser 1980; 652: 1-17.<br />
861. International Union Against <strong>Tuberculosis</strong> <strong>and</strong> Lung Disease. Criteria <strong>for</strong> discontinuation<br />
of vaccination programmes using Bacille Calmette-Guerin (BCG) in countries<br />
with a low prevalence of tuberculosis. A statement of the International Union<br />
Against <strong>Tuberculosis</strong> <strong>and</strong> Lung Disease. Tubercle Lung Dis 1994; 75: 179-80.<br />
862. World Health Organization. Global <strong>Tuberculosis</strong> Programme <strong>and</strong> Global<br />
Programme on Vaccines. Statement on BCG revaccination <strong>for</strong> the prevention of<br />
tuberculosis. WHO Wkly Epidem Rec 1995; 70: 229-31.<br />
863. Arbeláez MP, Nelson KE, Muñoz A. BCG vaccine effectiveness on preventing<br />
tuberculosis <strong>and</strong> its interaction with human immunodeficiency virus infection.<br />
Int J Epidemiol 2000; 29: 1085-91.<br />
864. Centers <strong>for</strong> Disease <strong>Control</strong> <strong>and</strong> Prevention. The role of BCG vaccine in the<br />
prevention <strong>and</strong> control of tuberculosis in the United States: a joint statement by<br />
the Advisory Council <strong>for</strong> the <strong>Elimination</strong> of <strong>Tuberculosis</strong> <strong>and</strong> the Advisory<br />
Committee on Immunization Practices.<br />
45(No.RR 4): 1-18.<br />
Morb Mortal Wkly Rep 1996;<br />
865. Fine PEM, Carneiro IAM, Milstien JB, Clements CJ. Issues relating to the use<br />
of BCG in immunization programmes.<br />
99.23: Geneva: WHO, 1999; 1-42.<br />
A discussion document. WHO/V&B/-<br />
866. Greenberg PD, Lax KG, Schechter CB. <strong>Tuberculosis</strong> in house staff. A decision<br />
analysis comparing the tuberculin screening strategy with the BCG vaccination.<br />
Am Rev Respir Dis 1991; 143: 490-5.<br />
867. Reichman LB, Jordan TJ, Greenberg PD. Decision analysis comparing the tuberculin<br />
screening strategy with BCG vaccine. (Correspondence).<br />
Dis 1992; 145: 732-3.<br />
Am Rev Respir<br />
868. Lincoln EM. The effect of antimicrobial therapy on the prognosis of primary<br />
tuberculosis in children. Am Rev Tuberc 1954; 69: 682-9.<br />
869. Ferebee SH, Mount FW, Anastasiades AA. Prophylactic effects of isoniazid on<br />
primary tuberculosis in children. Am Rev Respir Dis 1957; 76: 942-63.<br />
870. Mount FW, Ferebee SH. Preventive effects of isoniazid in the treatment of primary<br />
tuberculosis in children. N Engl J Med 1961; 265: 713-21.<br />
227
Change language